EDGEMOND JAMES
SEC CIK 1636178 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | CFO AND Treas | 27.6K | — | $263.38M | 102 | 2022-11-07 | 2026-06-22 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $840.04M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 102
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-23 16:34 | 2026-06-22 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +8,750 | 27.6K | +46% | +$1.28M |
| DMT | 2026-06-23 16:34 | 2026-06-22 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $538.15 | -8,750 | 18.9K | -32% | -$4.71M |
| DT | 2026-06-22 16:31 | 2026-06-18 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +10.0K | 28.9K | +53% | +$1.46M |
| DMT | 2026-06-22 16:31 | 2026-06-18 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $540.15 | -10.0K | 18.9K | -35% | -$5.40M |
| DT | 2026-06-16 16:35 | 2026-06-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-16 16:35 | 2026-06-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $549.17 | -10.0K | 18.9K | -35% | -$5.49M |
| DT | 2026-06-12 17:26 | 2026-06-11 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-12 17:26 | 2026-06-11 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $549.29 | -10.0K | 18.9K | -35% | -$5.49M |
| DT | 2026-06-09 18:06 | 2026-06-08 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-09 18:06 | 2026-06-08 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $547.50 | -10.0K | 18.9K | -35% | -$5.48M |
| DT | 2026-06-05 16:31 | 2026-06-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-05 16:31 | 2026-06-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $546.28 | -10.0K | 18.9K | -35% | -$5.46M |
| DT | 2026-06-02 16:33 | 2026-06-01 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-06-02 16:33 | 2026-06-01 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $547.87 | -10.0K | 18.9K | -35% | -$5.48M |
| DT | 2026-05-29 16:37 | 2026-05-28 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-05-29 16:37 | 2026-05-28 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $565.63 | -10.0K | 18.9K | -35% | -$5.66M |
| DT | 2026-05-27 16:31 | 2026-05-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-05-27 16:31 | 2026-05-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $572.94 | -10.0K | 18.9K | -35% | -$5.73M |
| DT | 2026-05-22 17:16 | 2026-05-21 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +10.0K | 28.9K | +53% | +$1.18M |
| DMT | 2026-05-22 17:16 | 2026-05-21 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $564.11 | -10.0K | 18.9K | -35% | -$5.64M |
| DMT | 2026-05-19 16:32 | 2026-05-18 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $122.17 | +10.0K | 28.9K | +53% | +$1.22M |
| DMT | 2026-05-19 16:32 | 2026-05-18 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $567.31 | -10.0K | 18.9K | -35% | -$5.67M |
| DT | 2026-05-15 17:04 | 2026-05-14 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-05-15 17:04 | 2026-05-14 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $574.47 | -10.0K | 18.9K | -35% | -$5.74M |
| DT | 2026-05-12 17:25 | 2026-05-11 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-05-12 17:25 | 2026-05-11 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $573.03 | -10.0K | 18.9K | -35% | -$5.73M |
| DT | 2026-05-11 07:37 | 2026-05-07 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-05-11 07:37 | 2026-05-07 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $578.58 | -10.0K | 18.9K | -35% | -$5.79M |
| DT | 2026-05-05 16:30 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-05-05 16:30 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $576.93 | -10.0K | 18.9K | -35% | -$5.77M |
| DT | 2026-05-01 16:56 | 2026-04-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-05-01 16:56 | 2026-04-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $572.61 | -10.0K | 18.9K | -35% | -$5.73M |
| DT | 2026-04-28 17:30 | 2026-04-27 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-28 17:30 | 2026-04-27 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $568.83 | -10.0K | 18.9K | -35% | -$5.69M |
| DT | 2026-04-24 16:32 | 2026-04-23 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-24 16:32 | 2026-04-22+ | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $572.34 | -10.0K | 18.9K | -35% | -$5.72M |
| DT | 2026-04-21 07:41 | 2026-04-20 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-21 07:41 | 2026-04-20 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $577.86 | -10.0K | 18.9K | -35% | -$5.78M |
| DT | 2026-04-17 16:56 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-17 16:56 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $577.18 | -10.0K | 18.9K | -35% | -$5.77M |
| DT | 2026-04-14 16:34 | 2026-04-13 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-14 16:34 | 2026-04-13 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $574.88 | -10.0K | 18.9K | -35% | -$5.75M |
| DT | 2026-04-10 16:33 | 2026-04-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-10 16:33 | 2026-04-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $577.89 | -10.0K | 18.9K | -35% | -$5.78M |
| DT | 2026-04-07 16:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-07 16:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $558.40 | -10.0K | 18.9K | -35% | -$5.58M |
| DT | 2026-04-06 16:41 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-06 16:41 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $561.50 | -10.0K | 18.9K | -35% | -$5.61M |
| DMT | 2026-03-31 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $593.17 | -10.0K | 28.8K | -26% | -$5.93M |
| DT | 2026-03-31 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-03-27 | 2026-03-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $535.90 | -10.0K | 20.2K | -33% | -$5.36M |
| DT | 2026-03-27 | 2026-03-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-03-24 | 2026-03-23 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $527.48 | -10.0K | 27.2K | -27% | -$5.27M |
| DT | 2026-03-24 | 2026-03-23 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | F - Tax | $536.12 | -8,786 | 18.9K | -32% | -$4.71M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | — | +19.5K | 27.7K | +238% | — |
| DMT | 2025-12-16 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $495.36 | -3,517 | 9,018 | -28% | -$1.74M |
| DT | 2025-12-16 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +3,517 | 11.7K | +43% | +$513.6K |
| DMT | 2025-12-09 | 2025-12-08 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $478.60 | -21.0K | 12.8K | -62% | -$10.05M |
| DT | 2025-12-09 | 2025-12-08 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 29.1K | +258% | +$3.07M |
| DMT | 2025-12-02 | 2025-12-01 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $479.99 | -21.0K | 14.5K | -59% | -$10.08M |
| DT | 2025-12-02 | 2025-12-01 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 29.1K | +258% | +$3.07M |
| DMT | 2025-11-26 | 2025-11-24 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $473.65 | -21.0K | 28.2K | -43% | -$9.95M |
| DT | 2025-11-26 | 2025-11-24 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 29.1K | +258% | +$3.07M |
| DMT | 2025-11-18 | 2025-11-17 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $470.36 | -21.0K | 10.6K | -67% | -$9.88M |
| DMT | 2025-11-18 | 2025-11-17 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 18.4K | New | +$3.07M |
| DT | 2025-11-12 | 2025-11-10 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 29.1K | +259% | +$3.07M |
| DMT | 2025-11-12 | 2025-11-10 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $452.07 | -21.0K | 21.9K | -49% | -$9.49M |
| DT | 2025-11-05 | 2025-11-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +21.0K | 29.1K | +259% | +$3.07M |
| DMT | 2025-11-05 | 2025-11-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $436.09 | -21.0K | 24.8K | -46% | -$9.16M |
| DMT | 2025-06-10 | 2025-06-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $325.37 | -12.0K | 8,118 | -60% | -$3.90M |
| DT | 2025-06-10 | 2025-06-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +12.0K | 20.1K | +148% | +$1.41M |
| DMT | 2025-06-03 | 2025-06-02 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $325.83 | -12.0K | 16.1K | -43% | -$3.91M |
| DT | 2025-06-03 | 2025-06-02 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $117.76 | +12.0K | 20.1K | +148% | +$1.41M |
| DM | 2024-11-05 | 2024-11-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $374.02 | -7,778 | 7,512 | -51% | -$2.91M |
| DM | 2024-11-05 | 2024-11-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 10.8K | +341% | +$991.6K |
| DM | 2024-10-29 | 2024-10-28 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 10.4K | +408% | +$991.6K |
| DM | 2024-10-29 | 2024-10-28 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $350.00 | -7,800 | 6,978 | -53% | -$2.73M |
| DM | 2024-10-22 | 2024-10-21 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $366.99 | -7,782 | 6,695 | -54% | -$2.86M |
| DM | 2024-10-22 | 2024-10-21 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 7,243 | New | +$991.6K |
| DM | 2024-10-15 | 2024-10-14 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $355.88 | -7,792 | 5,884 | -57% | -$2.77M |
| DM | 2024-10-15 | 2024-10-14 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $143.46 | +8,334 | 6,701 | New | +$1.20M |
| DM | 2024-10-08 | 2024-10-07 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 8,611 | +3,009% | +$991.6K |
| DM | 2024-10-08 | 2024-10-07 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $355.54 | -7,794 | 5,344 | -59% | -$2.77M |
| DM | 2024-10-01 | 2024-09-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 5,916 | New | +$991.6K |
| DM | 2024-10-01 | 2024-09-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $358.62 | -7,792 | 5,344 | -59% | -$2.79M |
| DM | 2024-09-24 | 2024-09-23 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 7,664 | New | +$991.6K |
| DM | 2024-09-24 | 2024-09-23 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $354.04 | -7,796 | 4,264 | -65% | -$2.76M |
| DM | 2024-09-17 | 2024-09-16 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $339.12 | -7,810 | 4,264 | -65% | -$2.65M |
| DM | 2024-09-17 | 2024-09-16 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.99 | +8,334 | 4,845 | New | +$991.6K |
| DM | 2024-09-10 | 2024-09-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $345.41 | -7,802 | 3,210 | -71% | -$2.69M |
| DM | 2024-09-10 | 2024-09-09 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.98 | +8,332 | 4,318 | New | +$991.4K |
| DM | 2024-09-04 | 2024-09-03 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $362.37 | -7,785 | 2,615 | -75% | -$2.82M |
| DM | 2024-09-04 | 2024-09-03 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.98 | +8,332 | 6,015 | New | +$991.4K |
| DM | 2024-08-26 | 2024-08-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $347.60 | -7,799 | 2,082 | -79% | -$2.71M |
| DM | 2024-08-26 | 2024-08-26 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.98 | +8,332 | 3,191 | New | +$991.4K |
| DM | 2024-08-20 | 2024-08-19 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $329.02 | -7,828 | 1,578 | -83% | -$2.58M |
| DM | 2024-08-20 | 2024-08-19 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $118.98 | +8,332 | 4,844 | New | +$991.4K |
| DM | 2024-05-16 | 2024-05-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $163.30 | +40.2K | 16.7K | New | +$6.56M |
| DM | 2024-05-16 | 2024-05-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $272.69 | -40.2K | 1,578 | -96% | -$10.95M |
Purchase Sale Sale after option exercise All abbreviations